Park KD - Search Results

1

Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.

Choi JW, Lee KT, Kim S, Lee YR, Kim HJ, Seo KJ, Lee MH, Yeon SK, Jang BK, Park SJ, Kim HJ, Park JH, Kim D, Lee DG, Cheong E, Lee JS, Bahn YS, Park KD. Choi JW, et al. Among authors: park jh, park kd, park sj. J Med Chem. 2021 Nov 11;64(21):15912-15935. doi: 10.1021/acs.jmedchem.1c01299. Epub 2021 Oct 18. J Med Chem. 2021. PMID: 34662122

2

Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents.

Park KD, Lee JH, Kim SH, Kang TH, Moon JS, Kim SU. Park KD, et al. Bioorg Med Chem Lett. 2006 Aug 1;16(15):3913-6. doi: 10.1016/j.bmcl.2006.05.033. Epub 2006 May 30. Bioorg Med Chem Lett. 2006. PMID: 16730982

3

Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl)berberine derivatives.

Park KD, Cho SJ, Moon JS, Kim SU. Park KD, et al. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6551-4. doi: 10.1016/j.bmcl.2010.09.045. Epub 2010 Sep 21. Bioorg Med Chem Lett. 2010. PMID: 20932752

4

Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy.

Woo SY, Kim JH, Moon MK, Han SH, Yeon SK, Choi JW, Jang BK, Song HJ, Kang YG, Kim JW, Lee J, Kim DJ, Hwang O, Park KD. Woo SY, et al. Among authors: park kd. J Med Chem. 2014 Feb 27;57(4):1473-87. doi: 10.1021/jm401788m. Epub 2014 Feb 5. J Med Chem. 2014. PMID: 24467268

5

A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model.

Lee JA, Kim JH, Woo SY, Son HJ, Han SH, Jang BK, Choi JW, Kim DJ, Park KD, Hwang O. Lee JA, et al. Among authors: park kd. Br J Pharmacol. 2015 Feb;172(4):1087-100. doi: 10.1111/bph.12973. Epub 2014 Dec 15. Br J Pharmacol. 2015. PMID: 25297649 Free PMC article.

6

9-O-butyl-13-(4-isopropylbenzyl)berberine, KR-72, is a potent antifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene expression.

Bang S, Kwon H, Hwang HS, Park KD, Kim SU, Bahn YS. Bang S, et al. Among authors: park kd. PLoS One. 2014 Oct 10;9(10):e109863. doi: 10.1371/journal.pone.0109863. eCollection 2014. PLoS One. 2014. PMID: 25302492 Free PMC article.

7

Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.

Choi JW, Jang BK, Cho NC, Park JH, Yeon SK, Ju EJ, Lee YS, Han G, Pae AN, Kim DJ, Park KD. Choi JW, et al. Among authors: park jh, park kd. Bioorg Med Chem. 2015 Oct 1;23(19):6486-96. doi: 10.1016/j.bmc.2015.08.012. Epub 2015 Aug 19. Bioorg Med Chem. 2015. PMID: 26337020

8

Antioxidant and Anti-Inflammatory Activities of a Natural Compound, Shizukahenriol, through Nrf2 Activation.

Park JH, Choi JW, Ju EJ, Pae AN, Park KD. Park JH, et al. Among authors: park kd. Molecules. 2015 Sep 2;20(9):15989-6003. doi: 10.3390/molecules200915989. Molecules. 2015. PMID: 26364630 Free PMC article.

9

Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists.

Vu HN, Kim JY, Hassan AH, Choi K, Park JH, Park KD, Lee JK, Pae AN, Choo H, Min SJ, Cho YS. Vu HN, et al. Among authors: park jh, park kd. Bioorg Med Chem Lett. 2016 Jan 1;26(1):140-4. doi: 10.1016/j.bmcl.2015.11.012. Epub 2015 Nov 5. Bioorg Med Chem Lett. 2016. PMID: 26598462

10

Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.

Cho NC, Cha JH, Kim H, Kwak J, Kim D, Seo SH, Shin JS, Kim T, Park KD, Lee J, No KT, Kim YK, Lee KT, Pae AN. Cho NC, et al. Among authors: park kd. Bioorg Med Chem. 2015 Dec 15;23(24):7717-27. doi: 10.1016/j.bmc.2015.11.016. Epub 2015 Nov 18. Bioorg Med Chem. 2015. PMID: 26631441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

678 results

Search Page